|Title:||Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study||Authors:||Lee, Jen-Chieh
|Keywords:||Clostridioides difficile infection; Congestive heart failure; Leukocyte count; Metronidazole; Recurrence; Severity score||Issue Date:||21-Jul-2022||Source:||Journal of the Formosan Medical Association = Taiwan yi zhi||Abstract:||
Although metronidazole is not recommended to treat Clostridioides difficile infection (CDI) in Western countries, it was still to be recommended for the treatment of non-severe CDI among Taiwanese adults in 2020. This controversy in the clinical role of metronidazole therapy for CDI was examined in a prospective clinical study.
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.